Iah Donovan-Banfield
Overview
Explore the profile of Iah Donovan-Banfield including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
223
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Using minor variant genomes and machine learning to study the genome biology of SARS-CoV-2 over time
Dong X, Matthews D, Gallo G, Darby A, Donovan-Banfield I, Goldswain H, et al.
Nucleic Acids Res
. 2025 Feb;
53(4).
PMID: 39970290
In infected individuals, viruses are present as a population consisting of dominant and minor variant genomes. Most databases contain information on the dominant genome sequence. Since the emergence of SARS-CoV-2...
2.
Maringer K, Cunningham-Oakes E, Lane F, Jones K, Francesco Rodrigues de Oliveira B, Baba-Dikwa A, et al.
Microbiology (Reading)
. 2025 Feb;
171(2).
PMID: 39912341
Scientific meetings and conferences are crucial in knowledge dissemination, fostering collaborations, professional development and inspiring innovative research. However, their traditional structure and organization have remained largely unchanged, perpetuating barriers that...
3.
Goldswain H, Penrice-Randal R, Donovan-Banfield I, Duffy C, Dong X, Randle N, et al.
Genome Med
. 2024 Jul;
16(1):89.
PMID: 39014481
Background: SARS-CoV-2 remains rapidly evolving, and many biologically important genomic substitutions/indels have characterised novel SARS-CoV-2 lineages, which have emerged during successive global waves of the pandemic. Worldwide genomic sequencing has...
4.
Francesco Rodrigues de Oliveira B, Donovan-Banfield I, Penrice-Randal R, Casey R, Goncalves-Carneiro D
Microbiology (Reading)
. 2024 Jun;
170(6).
PMID: 38860877
The past decade has seen growing awareness of the challenges faced by LGBTQIA+ scientists, including discrimination in the workplace and the lack of representation. Initiatives such as 500 Queer Scientists,...
5.
Penrice-Randal R, Bentley E, Sharma P, Kirby A, Donovan-Banfield I, Kipar A, et al.
bioRxiv
. 2024 Mar;
PMID: 38464327
Objectives: Immunocompromised individuals are susceptible to severe COVID-19 and potentially contribute to the emergence of variants with altered pathogenicity due to persistent infection. This study investigated the impact of immunosuppression...
6.
Sanderson T, Hisner R, Donovan-Banfield I, Hartman H, Lochen A, Peacock T, et al.
Nature
. 2023 Sep;
623(7987):594-600.
PMID: 37748513
Molnupiravir, an antiviral medication widely used against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), acts by inducing mutations in the virus genome during replication. Most random mutations are likely to...
7.
Kien D, Edenborough K, Da Silva Goncalves D, Vi T, Casagrande E, Le Duyen H, et al.
Virus Evol
. 2023 Sep;
9(1):vead016.
PMID: 37744653
The introgression of antiviral strains of into mosquito populations is a public health intervention for the control of dengue. Plausibly, dengue virus (DENV) could evolve to bypass the antiviral effects...
8.
Goldswain H, Dong X, Penrice-Randal R, Alruwaili M, Shawli G, Prince T, et al.
Genome Biol
. 2023 Mar;
24(1):47.
PMID: 36915185
Background: The mutational landscape of SARS-CoV-2 varies at the dominant viral genome sequence and minor genomic variant population. During the COVID-19 pandemic, an early substitution in the genome was the...
9.
Donovan-Banfield I, Cunningham-Oakes E
Nat Microbiol
. 2022 Nov;
7(12):1947-1948.
PMID: 36443459
No abstract available.
10.
Donovan-Banfield I, Penrice-Randal R, Goldswain H, Rzeszutek A, Pilgrim J, Bullock K, et al.
Nat Commun
. 2022 Nov;
13(1):7284.
PMID: 36435798
Molnupiravir is an antiviral, currently approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for treating at-risk COVID-19 patients, that induces lethal error catastrophe in SARS-CoV-2. How this...